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Previewsconserved in vertebrates and (2) Golgi
outposts are present in vertebrate neuron
dendrites (Horton et al., 2005). Many other
exciting questions remain to be ad-
dressed. Is the extent of Golgi-associated
acentrosomal MT nucleation different in
neuronal subtypes characterized by sig-
nificantly different dendritic complexity,
such as hippocampal neurons versus
Purkinje cells? Is this process of acentro-
somal MT nucleation used in other large,
highly polarized cell types in the devel-
oping brain, such as dividing radial glial
progenitors? What are the molecular
mechanisms regulating the position,
number and activity of Golgi-outpost
acentrosomal MT nucleation sites in
dendrites? Without any doubt, future
studies will tackle the questions raised
by these exciting new results.864 Neuron 76, December 6, 2012 ª2012 ElsREFERENCES
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In this issue of Neuron, Wright et al. (2012) identify two novel mediators of a-dystroglycan glycosylation in
mouse and unravel a novel function of glycosylated dystroglycan in axon guidance by providing evidence
for direct binding of a-DG to the midline chemorepellent Slit2.The addition of glycan chains is a key
step during the biosynthesis of many
extracellular proteins, membrane bound
receptors, and lipids. The structural
diversity of these sugar polymers, further
expanded by addition of sulfate, phos-
phate, and acetyl groups, is tremendous,
possibly exceeding that of proteins
(Ohtsubo and Marth, 2006). An increas-
ing number of human diseases have
been found to be caused by mutations
in genes encoding glycosyltransferases
and glycosidases (so-called congenital
disorders of glycosylation or CDG; Freezeet al., 2012). In most cases, the develop-
ment of the nervous system is affected
(Freeze et al., 2012), such as in dystrogly-
canopathies, which are all linked to
abnormal glycosylation of a-dystroglycan
(a-DG).
Dystroglycan is a transmembrane
protein expressed in various cell types
that binds to laminin, a key component
of the extracellular matrix (Hohenester
and Yurchenco, 2012). The dystroglycan
complex has thus been established as a
crucial mediator of communication be-
tween factors of the extracellular matrix.The biosynthesis pathway of dystrogly-
can entails intracellular posttranslational
proteolytic processing of a propeptide
derived from a single mRNA, creating
the a and b subunit of the mature
dystroglycan (Hohenester and Yurch-
enco, 2012). Interestingly, following this
initial cleavage, the two subunits reas-
semble noncovalently upon reaching the
plasma membrane. The b-dystroglycan
spans the plasma membrane, thus medi-
ating intracellular signaling processes,
while the a-dystroglycan is responsible
for extracellular binding of ligands.
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Figure 1. O-Glycosylation of a-Dystroglycan
(A) The posttranslational modification of a-Dystroglycan starts with the O-mannosylation of Ser/Thr
residues by POMT1/POMT2. POMT1,2 and POMGnT1 furthermore catalyze the biosynthesis of an
O-mannosyl-tetrasaccharide (NeuNAc-a-2,3-Gal-b-1,4-GlcNAc-b-1,2-Man) that has been shown to be
a major constituent of muscle and brain a-dystroglycan. This glycosidic residue is then further branched
andmodified by phosphorylation on themannitol subunit and subsequent postphosphoryl-glycosidations
required for laminin binding. These reactions are catalyzed by dystroglycanopathy-related glycosyltrans-
ferases such as LARGE, Fukutin and FKRP. LARGE activity results in repeating units of [-3-xylose-a1,
3-glucuronic acid-b1-] by xylosyltransferase and glucuronyltransferase activities (not shown), which
produce the postphosphoryl-carbohydrate chain. The exact function of ISPD and B3Gnt1 in a-DG glyco-
sylation remains to be determined.
(B) b3GnT1 was initially identified by its function in the synthesis of Poly-N-Acetyllactosamine by transfer-
ring a donor UDP-N-Acetylglucosamine (GlcNAc) to a Galactose (Gal) acceptor moiety creating a b-1,
3-glycosidic linkage.
Abbreviations: Man, Mannose; GalNAc, N-Acetylgalactosamine; NeuAc, N-acetylneuraminic acid.
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PreviewsGlyco-epitopes on a-dystroglycan are
recognized by Laminin, which through its
polymerization functions as the key com-
ponent in basement membrane assembly
during embryogenesis (Hohenester and
Yurchenco, 2012). To date, eight glyco-
syltransferases involved in the glycosyla-
tion of a-DG were identified through
genetic mapping in the dystroglycanop-
athy patients (Freeze et al., 2012; Fig-
ure 1). The development of mousemodels
of dystroglycanopathies has proven
difficult, and the dystroglycan conditional
knockout Pomgnt1 and Largemyd mice
are the only existing models (Waite
et al., 2012).
Here, Wright et al. (2012) performed
an ENU (N-Ethyl-N-nitrosurea) muta-
genesis screen in mouse to identify
novel genes controlling axon guidance
and describe two mutants exhibiting
severe and axon pathfinding defects
in the embryonic hindbrain and spinal
cord. The mutated genes encode ISPD
(isoprenoid synthase domain containing)
and B3Gnt1 (b-1,3-N-Acetyl-glucosami-
nyltransferase), two enzymes previously
linked to protein glycosylation. In prokary-otes and plants, ISPD is a nucleotidyl
transferase which functions in isoprenoid
precursor synthesis, a pathway that is
substituted by the mevalonate axis in
mammals. B3Gnt1 belongs to a family
of eight glycosyltransferases (BGnt1–8)
that are structurally related to b-1,3-
galactosyltransferases and differ in sub-
strate specificity and in vivo functions
(Henion et al., 2012). B3Gnts catalyze
the transfer of a donor UDP-N-Acetyl-
glucosamine to a Galactose acceptor
moiety creating a b-1,3-glycosidic linkage
(Figure 1).
How do B3Gnt1 and ISPD influence
axon guidance? Recently, it has been
shown that human ISPD is critical for initi-
ation of the glycosylation cascade, since
in the absence of ISPD, the serine/threo-
nine-O-mannosylation of a-DG in the
endoplasmic reticulum and subsequent
glycosylation events are severely reduced
(Roscioli et al., 2012; Willer et al., 2012;
Figure 1A). Accordingly, the authors found
that a-DG glycosylation is strongly dimin-
ished in the mouse ISPDmutant. Interest-
ingly, this is also the case in the B3Gnt1
mutant. As expected, in both mutants,Neuron 76,laminin binding to a-DG is abrogated.
Although the ISPD mutants die at birth,
the authors combined two different
B3Gnt1 mutant alleles to generate mice
that survive for several weeks and
develop many of the classic features of
dystroglycanopathies, such as muscular
dystrophy and neuronal radial migration
defects in cortex, hippocampus and
cerebellum.
To confirm that the axon guidance defi-
cits observed in ISPD and B3GnT1
mutants were linked to a-DG, Wright
et al. (2012), in this issue of Neuron,
used a DG conditional knockout line to
selectively inactivate DG in the epiblast.
This showed that axons also failed to
extend properly in the hindbrain and
spinal cord. Previous studies had linked
a-DG and neuronal migration in
mammals, but this is the first evidence
that it also plays a role in axon guidance.
However, the biggest surprise was
still to come, when the authors found
that the guidance of spinal cord commis-
sural axons was severely perturbed in
ISPD, B3Gnt1 and a-DG, mutants. In
normal embryos, most commissural
axons turn rostrally after crossing the
ventral midline (floor plate), whereas in
the three mutants, these axons either fail
to cross or grow randomly after crossing
(Figure 2A). Although midline crossing
defects have been detected in many
knockout mice with targeted deletion
of genes encoding axon guidance recep-
tors and ligands (Che´dotal, 2011), the
authors showed that Robo1/Robo2
double knockouts most faithfully recapit-
ulate commissural axons phenotypes
found in a-DG, ISPD, and B3Gnt1
mutants. They went on to show that
a-DG is highly expressed in floor plate,
as is the case for laminin and the Robo
ligands Slit1–3 (Brose et al., 1999), sug-
gesting that a-DG and its glycan chains
might bind and stabilize Slits at the
midline. Worthy of note, the fasciculation
of dorsal root ganglion (DRG) axons in
the dorsal funiculus is perturbed in
B3Gnt1 and ISPD mutants. As previous
studies showed that Slit2 is a branching
factor for DRG axons (Wang et al.,
1999), it suggests that glycosylated
a-DG might control Slit localization or
function outside the ventral midline.
Slits are large secreted proteins that act
at the ventral midline as repulsiveDecember 6, 2012 ª2012 Elsevier Inc. 865
FP
CNs
Control β3Gnt2 KO, Robo2 KO, Slit1/2 KO
VNO
basal
apical
A
B
C
A
P
A P
AOB
OB
?
PLM
PVC
Control dgn-1 
A P
Control DG KO, β3Gnt1 KO, ISPD KO, Robo1/2 KO
Figure 2. Axon Guidance Defects in Dystroglycan and Slit/Robo Mutants
(A) Spinal cord commissural neurons (CN) project axons toward the floor plate (FP) at the ventral midline
where Slits are highly expressed (purple). After crossing most CN axons grow along the FP in a rostral
direction. In a-DG, ISPD, and B3Gnt1 mutants and Robo1/Robo2 double knockouts, CN axons project
ventrally but they either stall at the FP or project after crossing in a caudal or rostral direction. In a-DG,
ISPD, and B3Gnt1mutants, Slits are not detected at the FP. The anterior (A) posterior (P) axis is indicated
in all panels.
(B) Robo2+ sensory neurons in the basal part of the vomeronasal organ (VNO) project to the posterior AOB.
By contrast, in B3Gnt2 knockouts, some basal VNO axons also project to the anterior AO. In the AOB of
control mice, Slit1 and Slit2 are expressed in a high-anterior to low-posterior gradient. It is not known if the
gradient is maintained in B3Gnt2 KO.
(C) Premature ventral extension of two classes of axons in the C. elegans dystroglycan mutant dg-1.
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Previewsguidance cues for ipsilaterally projecting
axons and postcrossing commissural
axons (Brose et al., 1999; Che´dotal,
2011). Two Slit2 fragments can be purified
from mammalian brain extracts (Nguyen
Ba-Charvet et al., 2001; Wang et al.,
1999): full-length Slit2 and a shorter
N-terminal fragment (Slit2-N). Both Slit2
and Slit2-N bind to Robo receptors (Ho-
henester, 2008; Figure 3). Proteolytic
processing of Slit2 generates a shorter
C-terminal fragment (Slit2-C) which is
unable to bind to Robo. Slit2-C function
is unknown but it binds to heparan sulfate
proteoglycans (HSPGs), another class of
glycoproteins (Hohenester, 2008). HSPGs
are also key components of the Slit/Robo
binding domain and are thought to stabi-
lize the interaction between the ligand866 Neuron 76, December 6, 2012 ª2012 Elsand its receptor (Figure 3). As Slit2-C
contains a laminin-G module found in all
proteins known to bind to a-DG, Wright
et al. (2012) next tested the ability of
Slit2-C to bind a-DG. They found that
Slit2-C binds to a-DG in a calcium-depen-
dent manner, and Slit2-C also binds to
floor plate in control mice but not in
B3Gnt1 mutant mice. Previous studies
have shown that only Slit2-N and full
length Slit2 mediate axon repulsion
(Nguyen Ba-Charvet et al., 2001). There-
fore, it will be important to show that full-
length Slit2, in addition to Slit2-C, binds
to a-DG.
A Robo-ectodomain (which binds all
Slits in vitro) was then use to localize Slit
proteins on spinal cord sections. As ex-
pected, a strong Robo binding wasevier Inc.observed at the floor plate, confirming
that this is the region with the highest
levels of Slits in the developing spinal
cord. Quite remarkably, Robo binding
was lost in B3Gnt1 mutant floor plate.
These data strongly suggest that glycosy-
lated a-DG, is orchestrating the distribu-
tion of Slit ligands in the extracellular
matrix at the midline.
Intriguingly, genetic and biochemical
evidence support a role for B3Gnt2, which
is closely related to B3Gnt1, in axon guid-
ance in sensory systems. In the mouse
accessory olfactory system, sensory
neurons in the basal vomeronasal organ
(VNO) project to the caudal half of
the accessory olfactory bulb (AOB; Fig-
ure 2B). In the AOB, Slit1 and Slit2 are
expressed in a high-anterior to low-
posterior gradient (Prince et al., 2009). In
Robo2 and in Slit1 knockouts, some basal
VNO axons invade the anterior AOB (Fig-
ure 2B), a phenotype recently described
in the B3Gnt2 knockout (Henion et al.,
2012). It is possible that BGNT2 acts to
shape the Slit gradient in the AOB or
modulate Slit interaction with Robo2
receptors on VNO axons, and this pheno-
type will need to be characterized more
closely.
These exciting results raise many
important questions. Are Slits the only
midline axon guidance proteins binding
to a-DG? Recent work has demonstrated
that DGN-1, the C. elegans homolog
of a-DG, is required for appropriate
development of the lumbar commissure
(Johnson and Kramer, 2012; Figure 3C).
Interestingly, in this system, genetic
evidence suggests that the a-DG path-
way is not only linked to Slit but also
to UNC-6/netrin-1. These data support
a role for dystroglycans in axon guidance
but also suggest that netrin-1 localization
might be perturbed in the a-DG and
B3GNT1 mutants. Further analysis will
be required to determine if other Slit
responsive axons are misguided in
a-DG/B3GNT1/ISPD mutants. Interest-
ingly, hindbrain pontine neurons, which
are commissural, express Robo recep-
tors, a-DG, Large and Fukutin, and in all
the corresponding mutants (as in WWS
patients) pontine neurons do not migrate
properly toward the floor plate (see refer-
ences in Waite et al., 2012).
Undoubtedly, this exciting study opens
new perspectives in the axon guidance
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Figure 3. Dystroglycan in Axon Guidance
Dystroglycan on floor plate cells binds to laminin in the ECM and to the laminin-G module of Slit2-C thus
controlling its distribution and presentation. Under the stabilizing action of HSPGs, full-length Slit2 and
Slit-N D2 domain binds to the first immunoglobulin domain of the Robo receptors at the surface of
commissural axons, inducing growth cone collapse or branching.
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Previewsfield and beyond, as Slit/Robo signaling
regulate cell-cell interaction in many
developing organs and in tumor cells
and similarly, many of the B3gnt enzymes
have also been shown to play a crucial
role in tumorigenesis in many different
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